| 000 | 00924 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517101408.0 | ||
| 264 | 0 | _c20171016 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1748-1716 | ||
| 024 | 7 |
_a10.1111/apha.12733 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkodad, M | |
| 245 | 0 | 0 |
_aDoes ivabradine balance dobutamine effects in cardiogenic shock? A promising new strategy. _h[electronic resource] |
| 260 |
_bActa physiologica (Oxford, England) _c10 2016 |
||
| 300 |
_a73-7 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aBenzazepines |
| 650 | 0 | 4 | _aDobutamine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIvabradine |
| 650 | 0 | 4 | _aShock, Cardiogenic |
| 700 | 1 | _aLim, P | |
| 700 | 1 | _aRoubille, F | |
| 773 | 0 |
_tActa physiologica (Oxford, England) _gvol. 218 _gno. 2 _gp. 73-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apha.12733 _zAvailable from publisher's website |
| 999 |
_c26116089 _d26116089 |
||